WINNINGHAM RICK E (Chief Executive Officer) reported 1 transaction at THERAVANCE BIOPHARMA, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 2/22/2024ACC: 0001415889-24-004968
DirectorOfficer· Chief Executive Officer
Since Aug 2018
-37.20K
Net shares
Net seller
$331.8K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
37.20K disposed
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
−37.20K
Price / share
$8.92
Trade value
$331.79K
% of position
2.3%
2/20/2024
1.60M→1.56M
Total
Net shares
−37.20K
Net value
-$331.79K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 2/20/2024 | F · Tax Withholding | −37.20K | $8.92 | $331.79K | 2.3% | 1.60M | 1.56M |
| Total | −37.20K | -$331.79K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Ordinary Shares
IndirectShares owned92.57K
Total
92.57K indirect92.57K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Ordinary Shares | 92.57K | Indirect |
| Total | 92.57K | 92.57K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported